Eli Lilly has seen success with its weight loss drugs, Mounjaro and Zepbound. Viking Therapeutics is an emerging competitor, with promising clinical trial results for its weight loss candidate, VK2735. Viking's oral formulation could offer a convenient alternative.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing